Neogenomics Inc (NASDAQ: NEO) is -45.63% lower on its value in year-to-date trading and has touched a low of $6.08 and a high of $19.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NEO stock was last observed hovering at around $7.18 in the last trading session, with the day’s loss setting it -4.85%.
Currently trading at $2.33M, the stock is -1.82% and -9.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.43 million and changing 1426315% at the moment leaves the stock -42.27% off its SMA200. NEO registered -56.55% loss for a year compared to 6-month loss of -56.37%. The firm has a 50-day simple moving average (SMA 50) of $7.9104 and a 200-day simple moving average (SMA200) of $12.4032.
The stock witnessed a -4.53% gain in the last 1 month and extending the period to 3 months gives it a -23.91%, and is 3.02% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.45% over the week and 5.01% over the month.
Neogenomics Inc (NEO) has around 2200 employees, a market worth around $921.46M and $672.36M in sales. Fwd P/E is 23.89. Profit margin for the company is -11.54%. Distance from 52-week low is 17.76% and -62.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-6.02%).
The EPS is expected to grow by 38.50% this year
357.0 institutions hold shares in Neogenomics Inc (NEO), with institutional investors hold 101.94% of the company’s shares. The shares outstanding are 128.36M, and float is at 126.92M with Short Float at 3.40%. Institutions hold 100.73% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 19.67 million shares valued at $272.82 million. The investor’s holdings represent 15.5612 of the NEO Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 14.12 million shares valued at $195.87 million to account for 11.1716 of the shares outstanding. The other top investors are BROWN ADVISORY INC which holds 8.77 million shares representing 6.9391 and valued at over $121.66 million, while T. ROWE PRICE INVESTMENT MANAGEMENT, INC. holds 5.3244 of the shares totaling 6.73 million with a market value of $93.35 million.
Neogenomics Inc (NEO) Insider Activity
The most recent transaction is an insider purchase by Kelly Michael Aaron, the company’s Director. SEC filings show that Kelly Michael Aaron bought 5,000 shares of the company’s common stock on May 27 ’25 at a price of $7.60 per share for a total of $38000.0. Following the purchase, the insider now owns 5000.0 shares.
Neogenomics Inc disclosed in a document filed with the SEC on May 12 ’25 that Stone Warren (Pres & Chief Operating Officer) bought a total of 5,700 shares of the company’s common stock. The trade occurred on May 12 ’25 and was made at $8.58 per share for $48895.0. Following the transaction, the insider now directly holds 0.11 million shares of the NEO stock.
Still, SEC filings show that on May 09 ’25, TETRAULT LYNN A. (Director) acquired 7,000 shares at an average price of $8.14 for $56974.0. The insider now directly holds 7,000 shares of Neogenomics Inc (NEO).
